Micro-management

By Jef Akst Micro-management © Prof. Ernest Giralt/IRB Barcelona The paper: L. He et al., “A microRNA component of the p53 tumour suppressor network,” Nature, 447:1130–34, 2007. (Cited in 151 papers) The finding: Comparing wild-type mouse embryonic fibroblasts to cells lacking the cell cycle regulator p53, molecular biologist Gregory Hannon of Cold Spring Harbor Laboratory identified a family

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

L. He et al., “A microRNA component of the p53 tumour suppressor network,” Nature, 447:1130–34, 2007. (Cited in 151 papers)

The finding:

Comparing wild-type mouse embryonic fibroblasts to cells lacking the cell cycle regulator p53, molecular biologist Gregory Hannon of Cold Spring Harbor Laboratory identified a family of microRNAs known as miR-34s whose transcription is directly regulated by p53. Overexpression of these microRNAs inhibited cell growth and caused cell cycle arrest, suggesting that the miR-34 family plays a critical role in the p53 tumor suppressor pathway.

The others:

In the summer of 2007, four other papers also independently confirmed that p53 controls miR-34 expression. Using different methodologies, these studies further highlighted miR-34’s effects on apoptosis and senescence, says Nikhil Chari, a molecular biologist at the MD Anderson Cancer Center in Houston, Texas. Hannon adds, “This raised a whole new class of possibilities for what downstream effectors were even ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies